LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
GLP-1 receptor agonists—including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)—are temperature-sensitive biologic medications used for type 2 diabetes and weight management. Proper storage is critical to maintain medication potency and therapeutic effectiveness. Most GLP-1 medications require refrigeration when unopened, though specific products allow limited room temperature storage. Understanding FDA-approved storage guidelines helps patients prevent medication degradation, avoid waste, and ensure optimal glycemic control. This guide explains refrigeration requirements, room temperature allowances, and practical storage strategies for GLP-1 medications at home and during travel.
Quick Answer: Most GLP-1 medications must be refrigerated at 36°F to 46°F (2°C to 8°C) when unopened, though specific products allow limited room temperature storage ranging from 14 to 56 days depending on the formulation.
Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications used primarily for type 2 diabetes management and, in some formulations, for chronic weight management. These biologic medications require specific storage conditions to maintain their stability, efficacy, and safety. Understanding proper storage is essential for patients to ensure optimal therapeutic outcomes.
GLP-1 medications are protein-based compounds that are sensitive to temperature extremes. The FDA-approved labels for GLP-1 receptor agonists—including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)—specify refrigeration as the primary storage method for unopened pens or vials. Tirzepatide (Mounjaro, Zepbound), while often grouped with GLP-1 medications, is technically a dual GIP/GLP-1 receptor agonist but follows similar storage requirements.
The standard storage temperature for unopened GLP-1 medications is between 36°F and 46°F (2°C to 8°C), which corresponds to typical refrigerator temperatures. Patients should store these medications in the main body of the refrigerator rather than in the door, where temperature fluctuations are more common. It is critical to avoid freezing these medications, as freezing damages the molecular structure of the active ingredient, rendering the medication ineffective.
Proper storage directly impacts medication potency. When stored outside recommended temperature ranges specified in FDA labeling, these medications may experience reduced efficacy, potentially leading to suboptimal glycemic control or inadequate weight management. Healthcare providers should educate patients on storage requirements at the time of prescribing to prevent medication waste and therapeutic failure.
Unopened GLP-1 pens and vials must generally be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) until their first use or until the expiration date printed on the packaging, whichever comes first. However, several products do allow limited room temperature storage before first use according to their FDA labels:
Wegovy (semaglutide): Up to 28 days at or below 86°F (30°C) before use
Trulicity (dulaglutide): Up to 14 days at or below 86°F (30°C) before use
Mounjaro and Zepbound (tirzepatide): Up to 21 days at or below 86°F (30°C) before use
Bydureon BCise (exenatide extended-release): Up to 4 weeks at or below 77°F (25°C) before use
When storing unopened GLP-1 medications, patients should keep them in their original carton to protect them from light exposure, which can also degrade the active ingredient. The carton provides an additional barrier against temperature fluctuations that may occur when the refrigerator door is opened. Patients should place the medication toward the back of a refrigerator shelf, away from the freezer compartment, to minimize the risk of accidental freezing.
It is essential to check that the refrigerator maintains a consistent temperature within the recommended range. Refrigerators that are overpacked, frequently opened, or have malfunctioning thermostats may not maintain adequate cooling. Patients can use an inexpensive refrigerator thermometer to monitor temperature and ensure compliance with storage requirements.
If a patient receives a GLP-1 medication by mail-order pharmacy, they should refrigerate it immediately upon arrival. Most specialty pharmacies ship these medications with cold packs and insulated packaging designed to maintain appropriate temperatures during transit. If there is uncertainty about whether the medication remained within safe temperature limits during shipping, patients should contact their pharmacy before using the medication.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Storage requirements for GLP-1 medications vary by product and depend on whether the product is a multi-dose pen (used multiple times) or a single-dose pen (used once and discarded). It's important to understand the difference between "after first use" storage for multi-dose pens versus allowable time at room temperature before use for single-dose pens.
Multi-dose pens (after first use):
Ozempic (semaglutide): May be stored at room temperature (up to 86°F/30°C) for up to 56 days or kept refrigerated after first use
Victoza and Saxenda (liraglutide): May be kept at room temperature (up to 86°F/30°C) for up to 30 days or refrigerated after first use
Byetta (exenatide): May be kept at room temperature (up to 77°F/25°C) for up to 30 days after first use
Single-dose pens (before use):
Wegovy (semaglutide): May be stored at room temperature (up to 86°F/30°C) for up to 28 days before use
Trulicity (dulaglutide): May be stored at room temperature (up to 86°F/30°C) for up to 14 days before use
Mounjaro and Zepbound (tirzepatide): May be stored at room temperature (up to 86°F/30°C) for up to 21 days before use
Bydureon BCise (exenatide extended-release): May be stored at room temperature (up to 77°F/25°C) for up to 4 weeks before use
Patients should write the date of first use on multi-dose pen labels to track how long the medication has been in use. After the specified room temperature storage period expires, the medication should be discarded even if doses remain, as potency cannot be guaranteed beyond these timeframes. Returning a product to the refrigerator does not extend the allowed time at room temperature.
Regardless of the specific product, GLP-1 pens should never be exposed to temperatures above their labeled maximum (either 86°F/30°C or 77°F/25°C, depending on the product). Excessive heat accelerates degradation of the active ingredient and may compromise efficacy. Patients should avoid storing pens in cars, near windows, or in other locations where temperature control is unreliable.
Improper storage of GLP-1 medications can result in loss of potency, reduced therapeutic efficacy, and potential safety concerns. When these medications are exposed to temperatures outside the recommended range, the peptide structure may degrade, leading to decreased biological activity. This degradation is often irreversible, meaning that returning the medication to proper storage conditions cannot restore its original potency.
If a GLP-1 medication is accidentally left out of the refrigerator before first use, the appropriate action depends on the duration and temperature of exposure. If an unopened pen has been at room temperature for less than the product-specific maximum duration (ranging from 14-56 days depending on the formulation) and below the maximum allowed temperature (77°F/25°C for exenatide products; 86°F/30°C for others), it may still be used according to FDA labeling. However, if the medication has been exposed to temperatures above these limits or has been frozen, it should be discarded immediately.
Freezing is particularly damaging to GLP-1 medications. Even if the medication is subsequently thawed, the molecular structure of the peptide is permanently altered, rendering it ineffective. Patients should always visually inspect their medication before use. According to FDA labeling, medication should not be used if it appears cloudy, contains particles, or shows visible changes in color or consistency (except for Bydureon, which becomes a suspension after mixing).
Using improperly stored GLP-1 medication may result in inadequate glycemic control for patients with type 2 diabetes, potentially leading to hyperglycemia. For patients using these medications for weight management, reduced potency may result in diminished weight loss. According to FDA labeling, the safety and efficacy of medication stored outside recommended conditions cannot be assured. Patients who suspect their medication has been stored improperly should consult their healthcare provider or pharmacist before administration.
Traveling with GLP-1 medications requires advance planning to maintain proper storage conditions throughout the journey. For short trips lasting less than the product-specific room temperature storage duration, patients can transport their medication at room temperature without refrigeration, provided temperatures remain below the maximum allowed (77°F/25°C for exenatide products; 86°F/30°C for others). For longer trips or when traveling with unopened pens, cooling solutions are necessary.
Insulated medication travel cases with reusable ice packs or cooling gel packs are effective for maintaining appropriate temperatures during travel. These cases are widely available and specifically designed for injectable medications. Patients should avoid direct contact between ice packs and medication pens, as this may cause freezing. Placing a barrier, such as a small towel or the medication's original carton, between the ice pack and the pen prevents this risk.
When flying, GLP-1 medications and associated supplies (needles, alcohol swabs, sharps container) should be carried in carry-on luggage rather than checked baggage, as cargo holds may experience temperature extremes. According to the Transportation Security Administration (TSA), passengers are permitted to carry injectable medications, syringes, and cooling accessories through security checkpoints. Patients should keep medications in their original labeled containers and may wish to carry a copy of their prescription, though this is not legally required in the US.
For international travel, patients should research the availability of refrigeration at their destination and plan accordingly. Many hotels provide in-room refrigerators upon request for medical purposes. If refrigeration is unavailable, patients should calculate whether their medication can remain at room temperature for the entire trip duration based on product-specific guidelines. For extended international travel, some patients may need to arrange for medication delivery to their destination or identify local pharmacies that can provide refills, though insurance coverage and medication availability vary by country.
Patients should also consider time zone changes when scheduling doses and plan to administer injections at consistent intervals relative to their usual schedule. Consulting with a healthcare provider before extended travel can help optimize dosing strategies and ensure adequate medication supply for the entire trip duration plus a few extra days in case of travel delays.
If an unopened GLP-1 pen was left at room temperature below the maximum allowed (77°F to 86°F depending on product) for less than the product-specific duration (14 to 56 days), it may still be used according to FDA labeling. However, if the medication was frozen or exposed to excessive heat, it should be discarded immediately as potency cannot be guaranteed.
After first use, multi-dose GLP-1 pens can typically be stored at room temperature for 30 to 56 days depending on the specific product. For example, Ozempic may be kept at room temperature (up to 86°F/30°C) for 56 days after first use, while Victoza and Saxenda allow 30 days at room temperature.
GLP-1 medications that have been frozen should be discarded immediately and not used, even after thawing. Freezing permanently damages the peptide structure, rendering the medication ineffective and potentially unsafe according to FDA labeling.
All medical content on this blog is created using reputable, evidence-based sources and is regularly reviewed for accuracy and relevance. While we strive to keep our content current with the latest research and clinical guidelines, it is intended for general informational purposes only.
This content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider with any medical questions or concerns. Use of this information is at your own risk, and we are not liable for any outcomes resulting from its use.
